C. Ansevin

发表

Treatment of ALS with pleconaril

C. Ansevin, C. F. Ansevin, 2001, Neurology.

Immunosuppressive treatment of rippling muscles in patients with myasthenia gravis

D. Pongratz, K. Ricker, W. Müller-Felber, 1999, Neuromuscular Disorders.

Identification of autoantibodies associated with rippling muscles and myasthenia gravis that recognize skeletal muscle proteins: possible relationship of antigens and stretch-activated ion channels.

G. Walker, C. Ansevin, T. Watkins, 1999, Biochemical and biophysical research communications.

Myasthenia, thymoma, presynaptic antibodies, and a continuum of neuromuscular hyperexcitability.

C. Ansevin, 2000, Neurology.

Rippling muscles and myasthenia gravis with rippling muscles.

C. Ansevin, D. Agamanolis, C. F. Ansevin, 1996, Archives of neurology.

C. Ansevin, C. F. Ansevin, 1980, Neurology.

Identification of skeletal muscle autoantigens by expression library screening using sera from autoimmune rippling muscle disease (ARMD) patients

M. Kesic, G. Walker, C. Ansevin, 2006, Journal of cellular biochemistry.

Variable waveforms in downbeat nystagmus imply short‐term gain changes

L. Dell’Osso, L. Abel, S. Traccis, 1983, Annals of neurology.

Phenotypic variability in rippling muscle disease.

C. Ansevin, 2000, Neurology.

The role of sleep in neuromuscular disorders

G. Siciliano, C. Ansevin, C. Angelini, 2023, Frontiers in Neurology.